New York Senate Bill S06443

New York 2025-2026 Regular Session

• Introduced: 3/14/25
• Refer: 3/14/25
• Refer: 1/7/26

Caption

Requires public residential buildings that receive funding through the department of housing and urban development or the division of housing and community renewal to have a supply of at least one dose of naloxone readily accessible for residential use as provided by OASAS.

Summary

Bill S06443 mandates that public residential buildings in New York, which receive funding from the Department of Housing and Urban Development or the Division of Housing and Community Renewal, must maintain a supply of naloxone. This life-saving medication, used to counteract opioid overdoses, must be readily accessible to residents in a common area of the building, such as a lobby or hallway. The bill outlines the responsibilities of the Office of Addiction Services and Supports (OASAS) to ensure that naloxone is available and maintained in these buildings, with funding sourced from OASAS and the opioid settlement fund.

Impact

The implementation of this bill will enhance public health safety in residential buildings by providing immediate access to naloxone, potentially reducing the number of fatalities due to opioid overdoses. It amends the public housing law to include specific requirements for naloxone accessibility, thereby impacting the operations of public housing authorities and the responsibilities of building managers. This law aims to create a safer environment for residents, particularly in areas with high rates of opioid use.

Sentiment

The sentiment surrounding Bill S06443 appears to be supportive, as it addresses a critical public health issue related to the opioid crisis. Discussions indicate a recognition of the importance of making naloxone accessible in residential settings, although specific committee discussions and voting history are not available to provide further insights into the level of bipartisan support or opposition.

Contention

While there is general support for the intent of the bill, some concerns may arise regarding the logistics of maintaining naloxone supplies and ensuring that residents are trained to use it effectively. Additionally, there could be differing opinions on the funding mechanisms and whether the opioid settlement fund will be sufficient to cover the costs associated with this initiative. Stakeholders such as housing authorities and addiction services may have varying levels of concern regarding implementation and resource allocation.